In medical news:

The FDA is taking steps to strike a balance between combating opioid abuse and misuse by curbing overprescribing and still providing appropriate care for patients’ chronic and end-of-life pain, according to a statement from FDA Commissioner Scott Gottlieb, MD. While pointing out that long-term opioid prescriptions continue to be written too often, Dr. Gottlieb said the agency’s ultimate goal is to support improved prescribing practices while encouraging the development of new nonopioid treatments. However, chronic pain patients are voicing concerns.

Read more here.

 

Leave a Comment

Your email address will not be published. Required fields are marked *